Interaction of dimercaptosuccinic acid (DMSA) with angiotensin II on calcium mobilization in vascular smooth muscle cells.
- 11 April 2003
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 65 (10) , 1741-1746
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effect of 2,3-dimercaptosuccinic acid on nephrosclerosis in the Dahl rat. I. Role of reactive oxygen speciesKidney International, 1996
- Effect of Chelation Treatment with Dimercaptosuccinic Acid (DMSA) on Lead-Related Blood Pressure ChangesEnvironmental Research, 1994
- Experimental Model of Lead Nephropathy. III. Continuous Low-level Lead AdministrationArchives of Environmental Health: An International Journal, 1993
- Experimental model of lead nephropathyEnvironmental Research, 1992
- Experimental model of lead nephropathy. I. Continuous high-dose lead administrationKidney International, 1992
- Chronic Lead Poisoning Treated with Dimercaptosuccinic AcidBasic & Clinical Pharmacology & Toxicology, 1991
- MESO-2,3-Dimercaptosuccinic Acid: Chemical, Pharmacological and Toxicological Properties of an Orally Effective Metal Chelating AgentAnnual Review of Pharmacology and Toxicology, 1990
- Contribution of Lead to Hypertension with Renal ImpairmentNew England Journal of Medicine, 1983
- Recent Advance in the Therapy of Metal Poisonings with Chelating AgentsHuman Toxicology, 1983
- DMSA and DMPS-Water Soluble Antidotes for Heavy Metal PoisoningAnnual Review of Pharmacology and Toxicology, 1983